1st generic semaglutide injection for weight loss approved: Health Canada
A generic semaglutide injection to promote weight loss is now approved in Canada, Health Canada says.
A generic semaglutide injection to promote weight loss is now approved in Canada, Health Canada says.
The regulator said the product submission, called Svemia, was filed by Canadian-based Apotex and is a generic version of the brand name drug Wegovy, sold by Denmark’s Novo Nordisk
Monday’s announcement by Health Canada marks its third such generic semaglutide product approval.
Health Canada said Svemia is approved for use once a week to treat people age 12 and older for chronic weight management in combination with a reduced-calorie diet and increased physical activity
The first two generic semaglutide injections were to treat Type 2 diabetes in adults.
Read more: https://www.cbc.ca/news/health/apotex-wegovy-weight-loss-glp1-generic-approval-9.7253817
Mainstream NewsBed Bug Infestation Forces Closure of Fort Simpson Schools
Two schools in Fort Simpson, N.W.T., will close starting Monday due to a bed bug infestation, with no confirmed reopening date.
Mainstream NewsThe Complex History of Bible Translations in Greenland and Labrador
Early Christian missionaries in Greenland and Labrador relied on Inuit converts to translate the Bible, revealing a complex interplay of cultural exchange and religious adaptation.
Mainstream NewsInuit-Led Pirutsiagutiit Program Replaces Child First Initiative
Federal government transfers $575M in child health and social support funding to Inuit organizations, ending uncertainty over previous program.
Mainstream NewsWhitehorse Students Engage With Canadian Astronauts Aboard the ISS
Students from Whitehorse schools connected with Canadian astronauts Jenni Gibbons and Joshua Kutryk, gaining insights into space exploration and inspiring future careers in science.